Literature DB >> 31217879

Alterations in amino acid levels and metabolite ratio of spinal cord in rat with myocardial ischemia-reperfusion injury by proton magnetic resonance spectroscopy.

Qian Wang1, Zhi-Xiao Li1, Yu-Juan Li1, Anne Manyande2, Shun-Yuan Li3, Mao-Hui Feng4, Duo-Zhi Wu5, Hong-Bing Xiang1.   

Abstract

OBJECTIVES: The mechanism behind spinal metabolites and myocardial ischemia-reperfusion (IR) injury is not well understood. Proton magnetic resonance spectroscopic analysis of spinal cord extracts provides a quick evaluation of the specific metabolic activity in rats with myocardial IR injury. We investigated the relationship between the IR-related variables and the changes in spinal metabolites.
METHODS: Proton magnetic resonance spectroscopy (1H-MRS) was used to assess the spinal metabolites of adult rats with and without myocardial IR injury (n = 6 per group). Myocardial IR injury was reproduced using intermittent occlusion of the left anterior descending coronary artery. We studied the relationship between the metabolite ratio measurement and IR-related variables. All rats underwent 1H-MRS, with the ratio of interest placed in different spinal cord segments to measure levels of twelve metabolites including N-acetylaspartate (NAA), taurine (Tau), glutamate (Glu), gamma amino acid butyric acid (GABA), creatine (Cr), and myoinositol (MI), etc.
Results: Rats with myocardial IR injury had higher concentration of Tau in the upper thoracic spinal cord (P < 0.05), and lower concentration of Gly and Glu in the cervical segment of the spinal cord (P < 0.05), when compared to the Control group. The ratios of glutamate/taurine (Glu/Tau), Glu/(GABA + Tau) and Glu/Total were significantly different between the IR group and the Control group in the upper thoracic spinal cord (P < 0.05). So were the ratios of Glu/(GABA + Tau) in the cervical segment (P < 0.05), and Glu/Tau and Glu/(GABA + Tau) in the lower thoracic spinal cord (P < 0.05).
CONCLUSIONS: These findings suggest that myocardial IR injury may be related to spinal biochemical alterations. It is speculated that these observed changes in the levels of spinal metabolites may be involved in the pathogenesis and regulation of myocardial IR injury.

Entities:  

Keywords:  Myocardial ischemia-reperfusion injury; metabolomics; proton nuclear magnetic resonance; spinal cord

Year:  2019        PMID: 31217879      PMCID: PMC6556651     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  5 in total

1.  Mapping Changes of Whole Brain Blood Flow in Rats with Myocardial Ischemia/Reperfusion Injury Assessed by Positron Emission Tomography.

Authors:  Xu-Chu Pan; Zhi-Xiao Li; Duo-Zhi Wu; Shun-Yuan Li; Hong-Bing Xiang; Yong-Tang Song
Journal:  Curr Med Sci       Date:  2019-07-25

2.  Neurochemical alterations of different cerebral regions in rats with myocardial ischemia-reperfusion injury based on proton nuclear magnetic spectroscopy analysis.

Authors:  Mao-Hui Feng; Zhi-Xiao Li; Qian Wang; Anne Manyande; Yu-Juan Li; Shun-Yuan Li; Weiguo Xu; Hong-Bing Xiang
Journal:  Aging (Albany NY)       Date:  2020-12-14       Impact factor: 5.682

3.  Characterization of novel lncRNAs in upper thoracic spinal cords of rats with myocardial ischemia-reperfusion injuries.

Authors:  Zhi-Xiao Li; Yu-Juan Li; Qian Wang; Zhi-Gang He; Mao-Hui Feng; Hong-Bing Xiang
Journal:  Exp Ther Med       Date:  2021-02-11       Impact factor: 2.447

4.  The Preventive Effect of Cardiac Sympathetic Denervation Induced by 6-OHDA on Myocardial Ischemia-Reperfusion Injury: The Changes of lncRNA/circRNAs-miRNA-mRNA Network of the Upper Thoracic Spinal Cord in Rats.

Authors:  Zhixiao Li; Yujuan Li; Zhigang He; Zhen Li; Weiguo Xu; HongBing Xiang
Journal:  Oxid Med Cell Longev       Date:  2021-11-29       Impact factor: 6.543

5.  Quantitative proteomics reveal the alterations in the spinal cord after myocardial ischemia‑reperfusion injury in rats.

Authors:  Shun-Yuan Li; Zhi-Xiao Li; Zhi-Gang He; Qian Wang; Yu-Juan Li; Qing Yang; Duo-Zhi Wu; Hao-Long Zeng; Hong-Bing Xiang
Journal:  Int J Mol Med       Date:  2019-09-17       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.